Figure 1: (A) Flowchart depicting the algorithm used for developing genome-directed primers from bacterial genomes. To test the usefulness of the mtGDPs for in vivo gene expression analysis, we asked ...

Gene amplifications and deletions frequently have pathogenetic roles in cancer. 30,000 radiation-hybrid mapped cDNAs provide a genomic resource to map these lesions with high resolution. We developed ...

New studies reveal that optical genome mapping (OGM) can detect chromosomal abnormalities linked to recurrent pregnancy loss, offering hope to affected families.

The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.

Researchers at Dartmouth–Hitchcock Medical Center investigated whether OGM could detect harmful chromosomal changes in patients with a family history or risk of recurrent pregnancy loss who had ...

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about half are caused by genetic or chromosomal issues.

The GA4GH is uniting researchers worldwide to share genomic data responsibly, set open standards, and improve oncology care ...

The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01 billion in 2025 and is projected to advance at a resilient ...

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...

In today’s interview, we speak to Matthew Loose about how real-time sequencing could transform cancer diagnostics and care.

The "DNA Methylation Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global DNA methylation market, valued at an estimated USD 1.64 billion in 2024, is anticipated to ...